← Back to Portfolio

SFJ Pharmaceuticals I

Company Listing
SFJ Pharmaceuticals I

SFJ Pharmaceuticals I and Pfizer are conducting a late-stage trial of Pfizer's potential kidney cancer treatment axitinib. Usually drugs are launched in Japan and Asia several years after they have been launched in the US and other developed countries, limiting the therapeutic options available to physicians and patients. SFJ Pharmaceuticals I intends to reduce this delay.

Location Pleasanton, California
CEO Robert DeBenedetto
Partner Ken Haas
Website www.sfj-pharma.com